Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives.
Moazamiyanfar R, Rezaei S, AliAshrafzadeh H, Rastegar-Pouyani N, Jafarzadeh E, Mouludi K, Khodamoradi E, Zhaleh M, Taeb S, Najafi M. Moazamiyanfar R, et al. Among authors: rastegar pouyani n. Curr Pharm Des. 2023;29(22):1713-1728. doi: 10.2174/1381612829666230426115424. Curr Pharm Des. 2023. PMID: 37185325 Review.
The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison between Recurrent and Non-Recurrent Patient-Derived CAFs.
Rastegar-Pouyani N, Montazeri V, Marandi N, Aliebrahimi S, Andalib M, Jafarzadeh E, Montazeri H, Ostad SN. Rastegar-Pouyani N, et al. Cancer Invest. 2023 Sep;41(7):656-671. doi: 10.1080/07357907.2023.2237576. Epub 2023 Jul 23. Cancer Invest. 2023. PMID: 37462514
Modulation of the immune system by melatonin; implications for cancer therapy.
Moslehi M, Moazamiyanfar R, Dakkali MS, Rezaei S, Rastegar-Pouyani N, Jafarzadeh E, Mouludi K, Khodamoradi E, Taeb S, Najafi M. Moslehi M, et al. Int Immunopharmacol. 2022 Jul;108:108890. doi: 10.1016/j.intimp.2022.108890. Epub 2022 May 24. Int Immunopharmacol. 2022. PMID: 35623297 Review.
Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths.
Karkon-Shayan S, Aliashrafzadeh H, Dianat-Moghadam H, Rastegar-Pouyani N, Majidi M, Zarei M, Moradi-Vastegani S, Bahramvand Y, Babaniamansour S, Jafarzadeh E. Karkon-Shayan S, et al. Among authors: rastegar pouyani n. Acta Histochem. 2023 Aug;125(6):152058. doi: 10.1016/j.acthis.2023.152058. Epub 2023 Jun 17. Acta Histochem. 2023. PMID: 37336070 Review.
35 results